Explore the frontier
Filter every story, video, company, game and lab experiment by topic, disease area, technology, company, development stage, format and audience.
15 results · 1 filter activeClear all
What if your genome could help select a treatment?
Sometimes it already does. The trick is knowing when a genetic result is truly useful.
What if a therapy were designed around one person’s tumor?
Every tumour carries its own mutations. Could a treatment be built to match them?
What if we could detect a cancer before symptoms appeared?
Finding cancer earlier sounds like pure good news. The details are more interesting.
Cancer FrontiersCAR-T cell therapy
A patient’s own immune cells, re-engineered to find and attack a target.
Cancer FrontiersLiquid biopsy & multi-cancer early detection
Looking for traces of tumour DNA in a blood sample.
How do cancer cells behave differently from healthy ones? – George Zaidan
An animated primer on what separates a cancer cell from a normal one, from uncontrolled division to evading the body's usual checks. Viewers also…
NCI Minute: CAR T-Cell Immunotherapy for Cancer Treatment
A short National Cancer Institute explainer on CAR T-cell therapy, in which a patient's own T cells are engineered to recognize and attack cancer.…
Checkpoint Inhibitors: Taking the Brakes Off the Immune System
Explains how tumors exploit immune 'checkpoints' to switch off T cells and how checkpoint-blocking drugs release those brakes. A useful foundation for understanding much…
Cancer FrontiersIntismeran autogene (V940 / mRNA-4157)
Phase 3 INTerpath-001 (NCT05933577) met its primary recurrence-free survival endpoint, announced Aug. 19, 2026; the companies say they will engage regulators on filings (company release).
Cancer FrontiersGalleri multi-cancer early detection test
PMA submitted Jan. 29, 2026; an FDA advisory panel voted 7–2 (one abstention) on Sept. 23, 2026 that benefits outweigh risks, with a final FDA decision pending.
Moderna
Nasdaq: MRNAModerna develops mRNA medicines and markets vaccines against COVID-19 and RSV. With Merck, it is developing intismeran autogene, an individualized neoantigen mRNA…
GRAIL
Nasdaq: GRALGRAIL develops blood tests for early cancer detection; its Galleri multi-cancer early detection test is sold in the U.S. as a laboratory-developed…